Background: Takayasu's arteritis (TA) is a chronic inflammatory disease that involves the aorta and its major branches; however, only limited data are available on TA in Taiwan. This study presents the clinical features, angiographic findings, and response to treatment of patients with TA at a single institute in Taiwan. Methods: A search of the hospital database for ICD9 code 446.7 (Takayasu's disease) between 1990 and 2010 was performed. Seven cases fulfilled the 1990 American College of Rheumatology diagnostic criteria for Takayasu's disease. Angiographic classification was made according to the guidelines of the 1994 International TA Conference in Tokyo. Results: All of our cases were female, and the median age at diagnosis was 27.5 years (range 14e36 years). Four patients had an angiographic classification of type I (57.1%), two were classified as type V (28.6%), and one was classified as type III (14.3%). The most common symptoms/ signs were dizziness and vascular bruits. Two patients underwent bypass surgery, four endovascular stenting, and one hybrid bypass with stenting. After a mean follow-up period of 50.3 AE 68.2 months (range 12.3e199.6 months), both the procedure success and survival rates were 100%. There were four restenosis cases (57.1%), one in the surgical bypass group without symptoms (33.3%), and three in the endovascular group (60%), five restenosis in 14 stents (35.7%). Also, these three patients received secondary endovascular procedure for percutaneous transluminal angioplasty or restenting. Conclusion: There have not been any case series reports about treatments of Takayasu's disease in Taiwan to date, based on a search of the PubMed/MEDLINE and Cochrane Library databases. Although endovascular treatment is becoming more prevalent, the restenosis rate is still high, and long-term follow-up and further strategy for restenosis management are the main challenges.
Introduction
Takayasu's arteritis (TA) is a chronic inflammatory disease that primarily affects the aorta and its main branches. TA is a rare disease, most commonly seen in Japan, Southeast Asia, India, and Mexico. The annual incidence of TA has been estimated at 2.6 per million in North America. 1 About 100e200 new cases of TA are registered each year in Japan 2 ;
so far, more than 5000 cases have been registered in Japan, 3 whereas there have only been sporadic case reports in Taiwan. For the purpose of providing objective data on the clinical course of TA in Taiwan, we reviewed the clinical symptoms/ signs, angiographic findings, treatments, and outcomes of this disease at our institute over a 20-year period.
Methods
Using ICD9 code 446.7 (Takayasu's disease), we performed a search of the hospital database and identified a total of 18 cases between 1990 and 2010. After a chart review, it was noted that seven patients fulfilled the American College of Rheumatology 1990 criteria for the diagnosis of TA. 4 Angiographic classification was made according to the guidelines established by the International TA Conference in Tokyo in 1994. 5 
Results

Patient characteristics
Seven cases fulfilled the American College of Rheumatology criteria for TA, all of whom were female with a median age at diagnosis of 27.5 years (range 14e36 years). Four of them had an angiographic classification of type I (57.1%), two were classified as type V (28.6%), and one was classified as type III (14.3%). The type III patient had received an aortobilateral iliac bypass at another hospital, and had been followed up at the Rheumatology department of our institution for medication. The demographic data of the patients are shown in Table 1 .
The symptoms and signs were reviewed by medical charts. Constitutional symptoms including fever, headache, dizziness, and malaise, and vascular findings including vascular bruits, absence of arm pulse, claudication of the extremities, visual disturbance, and syncope were noted (Table 2 ). Dizziness and vascular bruits (carotid artery) were found in all type I and type V cases, and an absence of arm pulse was found in five patients (83.3%).
Treatment modality
Surgical bypass group
Three patients underwent a surgical bypass. One received an aorto-bilateral carotid bypass in 1994, when a bifurcated Dacron graft (20 Â 10 mm) was interposed between the ascending aorta and bilateral common carotid artery (Fig. 1) . Another patient received an aorto-bilateral carotid bypass in 2006 with separated 7-mm grafts from the aorta to bilateral common carotid arteries, and then switched one 6-mm graft to connect from the right carotid graft to the right subclavian artery. The patient with an angiographic classification of type III received an aorto-bilateral iliac bypass at another hospital in 2008. Overall, no complications were recorded.
Endovascular revascularization group
Five patients underwent endovascular interventions, and stents were implanted in all patients (Table 3 , Fig. 2 ). Three patients received scheduled second-time interventions because of multiple-site stenosis. A total of 14 stents were implanted, and the primary success rate was 100%. Two immediate procedure-related complications were femoral artery thrombosis and femoral artery pseudoaneurysm that occurred at the vascular puncture site; both required urgent operation for vascular repair.
Restenosis
Up to the end of March 2012, with mean follow-up period of 50.3 AE 68.2 months (range 12.3e199.6 months) in total and 27.0 AE 22.1 months (range 12.3e64.9 months) in the endovascular group, the procedure success and long-term survival rates were both 100%. Four patients (57.1%) were still found to have graft, anastomosis site, and in-stent or stent edge stenosis. One patient from the surgical group experienced right aortocarotid bypass restenosis 4.5 years after the operation, and three patients in the endovascular group experienced restenosis with five stents (3/5 patients: 60%; 5 in 14 stents: 35.7%). All three patients received secondary intervention for restenosis, and mean days to secondary intervention were 322 days (Table 3) .
One patient suffered from multiple marginal restenosis 6 months after stents insertion at the distal left common carotid artery and proximal left subclavian artery (LSA); rupture of subclavian stent at aneurysm site was also found (Fig. 3) . Restenting was performed, but she suffered another episode of limb claudication after 6 months. Angiogram showed LSA restenosis; thus, percutaneous transluminal angioplasty (PTA) was performed. Another patient, who received right common carotid artery stent, experienced in-stent restenosis after 1 year. Restenting of a drug-eluting stent (DES) was performed.
Medication
Six patients received oral steroids with different initial doses and durations. One patient who was also diagnosed to have rheumatoid arthritis took cyclosporine. Five of the seven patients took antiplatelet agents.
Discussion
The average patient age of 27.5 years at diagnosis in our study is consistent with previous reports from the United States, Japan, South Korea, and China.
6e10 However, none of the patients was older than 40 years at the time of diagnosis in our study compared to 9.6% in China, as reported by Cong et al 10 in 125 cases, and 23.1% in South Korea, as reported by Park et al 11 in 108 cases. All of our patients were female, whereas other studies have shown varying female/male ratios ranging from 1.2:1 to 9.4:1. All of our type I and type V TA patients complained about dizziness and vascular bruits at the time of diagnosis. The "classic" symptoms of TA, such as an absence of arm pulse, extremity claudication, and visual disturbance, were present in most of our cases. 12 The predominant anatomic lesions were stenosis or occlusion, which is similar to the angiographic features reported in other countries, 10, 11 albeit that the involvement of different arteries shows variation by country. Table 3 Treatment modality in the endovascular group. In our study, type I was the most frequent angiographic disease pattern, which is similar to that observed in China, South Korea, and Colombia. In contrast, type V is the most commonly found pattern in Thailand, Brazil, India, and Japan, but less commonly found in China and Taiwan (Table 4) . The different distribution of vascular involvement in different geographical areas might indicate that ethnic factors play an important role in TA.
Even though there were a limited number of cases in our study, we still observed a potentially longer patency in the surgical bypass group. Although the role of endovascular stenting/PTA in TA has been progressing recently, long-term follow-up data are still lacking. Tyagi et al 13 reported successful angioplasty over renal arteries in TA in 89.3% of 54 cases (67 of 75 lesions attempted), with restenosis occurring in seven of 52 (13.5%) lesions over a follow-up period of 43.4 months. Sharma et al 14 reported 16 stents over different sites with restenosis in two carotid stents over a short-term follow-up period of 6 months. Sakaida et al 15 placed 14 stents over carotid and subclavian arteries with a 91% success rate, and only one case of restenosis in 12 months of follow-up. In our endovascular group, all three restenosis patients required reintervention. The restenosis period occurred about 1 year later (mean 322 days, range 212e394 days). A recent study in China also observed that restenosis occurred mostly in the first year. 10 Sharma et al 17 had mentioned that the noncompliant and fibrotic nature vessel wall in TA requires higher balloon inflation pressure, and this may expose the vessel wall to increased risk of injury. Stenostic vessels in TA were often long lesions, and it has been noted that higher rates of restenosis correlate with the length of lesions in both atherosclerosis and TA. Better results of PTA in TA were observed in renal arteries, wherein lesions were short and focal. 13 However, the long-term follow-up of stent patency and the management of restenosis are the most difficult issues to be faced in the future. Bypass surgery remains the gold standard for achieving long-term patency. Endovascular treatment provides symptoms relief in a shorter period for those who are reluctant to undergo this operation. Moreover, doctors should always preserve the anastomosis sites for future bypass surgery while they are performing endovascular stents placement.
There have been sporadic cases of DES implantation over carotid arteries in Takayasu's disease. The long-term patency was inconsistent; more studies are necessary to gauge the effectiveness of DESs in Takayasu's disease.
Taipei Veterans General Hospital is a tertiary referral medical center in Taiwan, but even so there have only been seven confirmed cases of Takayasu's disease in the past 20 years. In addition, no other case series have been reported in Taiwan. The realistic epidemiological phenomenon of Takayasu's disease in Taiwan needs more interhospital cohort study.
In conclusion, although the number of cases is limited in this study, this is the only reported series of Takayasu's disease in Taiwan. Most of our cases had an angiographic classification of type I. Endovascular treatment for this disease is an alternative choice with a high initial success rate and low complication rate; restenosis rates are high and usually occur in the first year. The management of restenosis for patients who receive endovascular stents is the main challenge. 
